Aspirin reduces the incidence of metastatic Braf mutant colorectal cancer in a preclinical trial

被引：0
|
作者：
Kane, A. [1 ,2 ,3 ]
Mckeone, D. [1 ]
Liu, C. [1 ,2 ]
Borowsky, J. [1 ,2 ,3 ]
Leggett, B. [1 ,2 ,4 ]
Whitehall, V. [1 ,2 ,3 ]
机构：
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Brisbane, Qld, Australia
[3] Pathol Queensland, Brisbane, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
213
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] Aspirin reduces the incidence of metastasis in a preclinical study of Braf mutant colorectal cancer
    Kane, Alexandra
    Liu, Cheng
    Fennell, Lochlan
    McKeone, Diane
    Borowsky, Jennifer
    Leggett, Barbara
    Whitehall, Vicki
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Curcumin Chemoprevention Reduces the Incidence of Braf Mutant Colorectal Cancer in a Preclinical Study
    Kane, Alexandra M.
    Liu, Cheng
    Akhter, Dewan T.
    McKeone, Diane M.
    Bell, Craig A.
    Thurecht, Kristofer J.
    Leggett, Barbara A.
    Whitehall, Vicki L. J.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4326 - 4332
  • [3] Curcumin Chemoprevention Reduces the Incidence of Braf Mutant Colorectal Cancer in a Preclinical Study
    Alexandra M. Kane
    Cheng Liu
    Dewan T. Akhter
    Diane M. McKeone
    Craig A. Bell
    Kristofer J. Thurecht
    Barbara A. Leggett
    Vicki L. J. Whitehall
    Digestive Diseases and Sciences, 2021, 66 : 4326 - 4332
  • [4] Curcumin chemoprevention reduces the incidence of BRAF-mutant colorectal cancer in a preclinical study
    Kane, A.
    Liu, C.
    Akhter, D.
    Mckeone, D.
    Bell, C.
    Thurecht, K.
    Leggett, B.
    Whitehall, V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 162 - 163
  • [5] Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia
    Alexandra M. Kane
    Cheng Liu
    Lochlan J. Fennell
    Diane M. McKeone
    Catherine E. Bond
    Pamela M. Pollock
    Graeme Young
    Barbara A. Leggett
    Vicki L. J. Whitehall
    British Journal of Cancer, 2021, 124 : 1820 - 1827
  • [6] Aspirin reduces the incidence of metastasis in a pre-clinical study of Braf mutant serrated colorectal neoplasia
    Kane, Alexandra M.
    Liu, Cheng
    Fennell, Lochlan J.
    McKeone, Diane M.
    Bond, Catherine E.
    Pollock, Pamela M.
    Young, Graeme
    Leggett, Barbara A.
    Whitehall, Vicki L. J.
    BRITISH JOURNAL OF CANCER, 2021, 124 (11) : 1820 - 1827
  • [7] Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
    Yaeger, Rona
    Cercek, Andrea
    O'Reilly, Eileen M.
    Reidy, Diane L.
    Kemeny, Nancy
    Wolinsky, Tamar
    Capanu, Marinela
    Gollub, Marc J.
    Rosen, Neal
    Berger, Michael F.
    Lacouture, Mario E.
    Vakiani, Efsevia
    Saltz, Leonard B.
    CLINICAL CANCER RESEARCH, 2015, 21 (06) : 1313 - 1320
  • [8] Management of BRAF-mutant metastatic colorectal cancer
    Burge, Matthew
    Whitehall, Vicki
    COLORECTAL CANCER, 2016, 5 (04) : 131 - 133
  • [9] Aspirin reduces risk of colorectal cancer incidence, mortality
    不详
    FORMULARY, 2010, 45 (11) : 341 - 341
  • [10] Treatment options in BRAF-mutant metastatic colorectal cancer
    Bernabe-Ramirez, Carolina
    Patel, Rajvi
    Chahal, Jaspreet
    Saif, Muhammad Wasif
    ANTI-CANCER DRUGS, 2020, 31 (06) : 545 - 557
12345